SEC Form 4 · accession 0001209191-17-047698
INTEGRA LIFESCIENCES HOLDINGS CORP · IART
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald E Morel Jr.
Director
Period of report
Aug 3, 2017
Accepted (ET)
Aug 4, 2017 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000917520
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 3, 2017 | P | 2,500 | $49.293 | A | 29,612 | D | |
| Common Stock | Aug 4, 2017 | P | 7,500 | $49.23 | A | 37,112 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price shown above represents the weighted average price of the shares purchased. The range of sale prices was $49.26 to $49.34.